DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Erygel (Erythromycin Topical) - Indications and Dosage



ERYGEL® Topical Gel USP, 2% is indicated for the topical treatment of acne vulgaris.


ERYGEL® Topical Gel USP, 2% should be applied sparingly as a thin film to affected area(s) once or twice a day after the skin is thoroughly cleansed and patted dry. If there has been no improvement after 6 to 8 weeks, or if the condition becomes worse, treatment should be discontinued, and the physician should be reconsulted. Spread the medication lightly rather than rubbing it in. There are no data directly comparing the safety and efficacy of b.i.d. versus q.d. dosing.


ERYGEL® (Erythromycin) Topical Gel USP, 2% is available as follows:

30 g sealed metal tube (NDC 40076-315-94)

60 g sealed metal tube (NDC 40076-315-96)


Note - FLAMMABLE. Keep away from heat and flame. Store and dispense in original container. Keep tube tightly closed. Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature].

Prestium Pharma

Manufactured for Prestium Pharma, Inc.

Newtown, PA 18940

Manufactured by Perrigo

Yerham 80500, Israel

Made in Israel Rev 08/13

:6J400 ZH J1

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017